Suneel Kamath, MD, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, shares his insights on the current funding disparities and the way forward to creating equity in allocation for cancer research. Current funding allocation can be relatively random, with advocacy playing a key role, but moving forward he advises using a set of criteria representing the overall burden of each disease to inform allocation. This interview took place at the 2025 American Society of Clinical Oncology (ASCO) meeting in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.